Headlines AbbVie Reports Q2 Today. The Post-Humira Story Is Winning. The Cheap InvestorJuly 31, 20260 Skyrizi and Rinvoq have already replaced Humira. The $10.9B Apogee deal adds the next chapter.
Newsletters Write This Down: A.R.M. The Cheap InvestorJuly 31, 20260 July 31, 2026 Three Open Files the Market Closed Early Featured: Three Open Files the Market Closed Early Sponsored Below is…
Newsletters The Bond Market Just Voted No Confidence The Cheap InvestorJuly 31, 20260 July 31, 2026 The Bond Market Just Voted No Confidence Words without action pushed the 30-year to a 2007-era high….
TCI Exclusives Three Dissenters Just Changed Everything The Cheap InvestorJuly 31, 20260 The Fed held rates steady, but the 9-3 vote was the most hawkish FOMC split since 2016. September is now live.